LI
CRL icon

LRI Investments’s Charles River Laboratories CRL Stock Holding History

LRI Investments’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$680 Buy
+3
New +$534 ﹤0.01% 1471
2025
Q2 		– Sell
-572
Closed -$86.1K – 1275
2025
Q1 		$86.1K Sell
572
-377
-40% -$63.2K 0.01% 446
2024
Q4 		$175K Hold
949
– – 0.02% 300
2024
Q3 		$187K Sell
949
-1,263
-57% -$262K 0.02% 294
2024
Q2 		$457K Buy
2,212
+2,200
+18,333% +$498K 0.05% 124
2024
Q1 		$3.25K Buy
+12
New +$2.87K ﹤0.01% 690

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

LRI Investments's CRL Position: Q2 2026 in Review

LRI Investments opened a new position in Charles River Laboratories (CRL) in Q2 2026: 3 shares worth $680. The stake represents ﹤0.01% of the portfolio and ranks #1471 among its holdings. This is a return to the name: LRI Investments previously reported a position in CRL as recently as Q1 2025.

LRI Investments first reported a position in CRL in Q1 2024 and has held it in 6 quarters since. The position peaked at $457K in Q2 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • LRI Investments held 3 shares of Charles River Laboratories worth $680 as of Q2 2026.
  • Charles River Laboratories was a new LRI Investments position in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #1471 holding.
  • LRI Investments first reported a position in Charles River Laboratories in Q1 2024 and has held it in 6 quarters since.
  • LRI Investments's Charles River Laboratories position peaked at $457K in Q2 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.